You cannot currently buy a generic Neupro (rotigotine) product. However, this may change after the first patent expires in March 2019, unless new patents or lawsuits are filed. Although rotigotine is considered the "generic name" for Neupro, it is not actually a generic version of the drug.
Neupro® (rotigotine) is a prescription medication approved to treat Parkinson's disease and restless legs syndrome (RLS). It is a skin patch that is applied just once a day, and belongs to a class of medications known as dopamine agonists.
Neupro is made by UCB, Inc. At this time, there are no generic Neupro products available.
The first patent for Neupro is set to expire in March 2019. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten the exclusivity period. This could include such things as lawsuits or patents for new Neupro uses. Once the patent expires, there may be several companies that manufacture a generic Neupro drug.
No -- rotigotine is the active ingredient in Neupro, not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.